Similar articles

• Systemic treatment of tinea versicolor with ketoconazole in forty-four patients.

  Jolliffe DS, Ngai YL. Jolliffe DS, et al. Clin Exp Dermatol. 1981 Nov;6(6):625-8. doi: 10.1111/j.1365-2230.1981.tb02367.x. Clin Exp Dermatol. 1981. PMID: 6280912 No abstract available.
• Oral ketoconazole in the treatment of leishmaniasis.

  Urcuyo FG, Zaias N. Urcuyo FG, et al. Int J Dermatol. 1982 Sep;21(7):414-6. doi: 10.1111/j.1365-4362.1982.tb03163.x. Int J Dermatol. 1982. PMID: 6290403 Clinical Trial. No abstract available.
• Treatment of pityriasis versicolor: comparison of sulconazole nitrate 1% solution and clotrimazole 1 % solution.

  Tham SN. Tham SN. Australas J Dermatol. 1987 Dec;28(3):123-5. doi: 10.1111/j.1440-0960.1987.tb00351.x. Australas J Dermatol. 1987. PMID: 3332758 Clinical Trial. No abstract available.
• Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

  Heel RC, Brogden RN, Carmine A, Morley PA, Speight TM, Avery GS. Heel RC, et al. Drugs. 1982 Jan-Feb;23(1-2):1-36. doi: 10.2165/00003495-198223010-00001. Drugs. 1982. PMID: 6276122 Review. No abstract available.
• Pityriasis versicolor: a review of pharmacological treatment options.

  Gupta AK, Kogan N, Batra R. Gupta AK, et al. Expert Opin Pharmacother. 2005 Feb;6(2):165-78. doi: 10.1517/14656566.6.2.165. Expert Opin Pharmacother. 2005. PMID: 15757415 Review.